In today’s session Colgate-Palmolive Company (CL) registered an unusually high (540) contracts volume of call trades. Someone, most probably a professional was a very active buyer of the November, 2016 call, expecting serious CL increase. With 540 contracts traded and 20544 open interest for the Nov, 16 contract, it seems this is a quite bullish bet. The option with symbol: CL161118C00070000 closed last at: $2.83 or 2.9% up. About 1.02M shares traded hands. Colgate-Palmolive Company (NYSE:CL) has risen 5.09% since March 15, 2016 and is uptrending. It has underperformed by 0.40% the S&P500.
Analysts await Colgate-Palmolive Company (NYSE:CL) to report earnings on November, 4. They expect $0.73 earnings per share, up 1.39% or $0.01 from last year’s $0.72 per share. CL’s profit will be $648.74 million for 24.77 P/E if the $0.73 EPS becomes a reality. After $0.70 actual earnings per share reported by Colgate-Palmolive Company for the previous quarter, Wall Street now forecasts 4.29% EPS growth.
Colgate-Palmolive Company (NYSE:CL) Ratings Coverage
Out of 16 analysts covering Colgate-Palmolive (NYSE:CL), 3 rate it a “Buy”, 0 “Sell”, while 13 “Hold”. This means 19% are positive. Colgate-Palmolive has been the topic of 27 analyst reports since July 21, 2015 according to StockzIntelligence Inc. The firm has “Hold” rating by Zacks given on Friday, September 4. The firm has “Hold” rating given on Wednesday, August 5 by Zacks. BNP Paribas downgraded Colgate-Palmolive Company (NYSE:CL) on Friday, July 29 to “Neutral” rating. The rating was maintained by Citigroup on Thursday, April 14 with “Buy”. The firm has “Neutral” rating given on Friday, July 29 by UBS. The firm has “Outperform” rating given on Friday, January 15 by BNP Paribas. The company was initiated on Tuesday, July 21 by Sterne Agee CRT. The company was downgraded on Monday, January 4 by RBC Capital Markets. UBS maintained Colgate-Palmolive Company (NYSE:CL) rating on Friday, July 31. UBS has “Neutral” rating and $72 price target. Bank of America upgraded the shares of CL in a report on Monday, September 12 to “Buy” rating.
According to Zacks Investment Research, “Colgate-Palmolive is a leading global consumer products company, tightly focused on Oral Care, Personal Care, Household Surface Care, Fabric Care and Pet Nutrition. Colgate sells its products in countries and territories around the world under such internationally recognized brand names as Colgate, Palmolive, Mennen, Softsoap, Irish Spring, Protex, Sorriso, Kolynos, Ajax, Axion, Soupline, Suavitel and Fab, as well as Hill’s Science Diet and Hill’s Prescription Diet pet foods. (Company Press Release)”
Insitutional Activity: The institutional sentiment decreased to 0.87 in Q2 2016. Its down 0.04, from 0.91 in 2016Q1. The ratio fall, as 47 funds sold all Colgate-Palmolive Company shares owned while 440 reduced positions. 53 funds bought stakes while 371 increased positions. They now own 618.55 million shares or 5.94% less from 657.64 million shares in 2016Q1.
The Massachusetts-based Bollard Group has invested 0.21% in Colgate-Palmolive Company (NYSE:CL). Savant Capital Limited Com last reported 0.17% of its portfolio in the stock. Manikay Prns Ltd Liability reported 600,200 shares or 3.35% of all its holdings. Fincl Bank Of Montreal Can, a Ontario – Canada-based fund reported 886,458 shares. Veritas Investment Management Ltd Liability Partnership has invested 0.01% of its portfolio in Colgate-Palmolive Company (NYSE:CL). Gemmer Asset Management Lc owns 811 shares or 0.03% of their US portfolio. The Minnesota-based Murphy Pohlad Asset Mgmt Ltd Co has invested 1.74% in Colgate-Palmolive Company (NYSE:CL). Cetera Limited Liability Com has invested 0.13% of its portfolio in Colgate-Palmolive Company (NYSE:CL). Blue Bell Private Wealth Management Limited Co holds 0.01% of its portfolio in Colgate-Palmolive Company (NYSE:CL) for 300 shares. Btim Corp, a Massachusetts-based fund reported 572,648 shares. Voya Invest Mgmt Limited Liability Company owns 446,137 shares or 0.08% of their US portfolio. The Connecticut-based Webster Bancorp N A has invested 0.04% in Colgate-Palmolive Company (NYSE:CL). Stifel Corp has 0.1% invested in the company for 305,922 shares. South State has 0.36% invested in the company for 32,981 shares. Ubs Asset Mgmt Americas Incorporated, a Illinois-based fund reported 2.89M shares.
Insider Transactions: Since May 3, 2016, the stock had 0 insider purchases, and 17 sales for $21.98 million net activity. On Friday, July 15 Verduin Patricia sold $274,877 worth of the stock or 3,666 shares. $1.16 million worth of Colgate-Palmolive Company (NYSE:CL) shares were sold by CAHILL JOHN T. The insider SADOVE STEPHEN I sold $653,927. 14,000 shares were sold by HUSTON JOHN J, worth $1.05M on Wednesday, August 10. 78,849 Colgate-Palmolive Company (NYSE:CL) shares with value of $5.89M were sold by Wallace Noel R.. Dolan Victoria L sold $1.39 million worth of Colgate-Palmolive Company (NYSE:CL) on Tuesday, May 3. HANCOCK ELLEN M sold 4,566 shares worth $328,085.
Colgate-Palmolive Company is a consumer products company, whose products are marketed in over 200 countries and territories throughout the world. The company has a market cap of $64.27 billion. The Company’s divisions include Oral, Personal and Home Care, and Pet Nutrition. It has a 46.73 P/E ratio. The Oral, Personal and Home Care product segment is operated through over five geographic divisions, which include North America, Latin America, Europe/South Pacific, Asia and Africa/Eurasia.
CL Company Profile
Colgate-Palmolive Company (Colgate), incorporated on July 25, 1923, is a consumer products company, whose products are marketed in over 200 countries and territories throughout the world. The Firm operates in two product divisions: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through over five geographic divisions, which include North America, Latin America, Europe/South Pacific, Asia and Africa/Eurasia. The Company’s oral care products include Colgate Total; Colgate Sensitive Pro-Relief; Colgate Max Fresh; Colgate Maximum Cavity Protection with Sugar Acid Neutralizer; Colgate Optic White and Colgate Luminous White toothpastes, and Colgate Optic White, Colgate Total and Colgate Plax mouthwashes. Colgate’s Oral Care business also includes pharmaceutical products for dentists and other oral health professionals. The Firm sells its personal care products under the Palmolive, Protex and Softsoap brands. The Company, through its Hill’s Pet Nutrition segment (Hill’s), makes pet nutrition products for dogs and cats with products marketed in over 80 countries across the world.
Another recent and important Colgate-Palmolive Company (NYSE:CL) news was published by Fool.com which published an article titled: “Colgate-Palmolive Stock in 5 Charts” on October 07, 2016.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.